Home
Perceptive Advisors reported a 8.9% stake in Inhibikase Therapeutics IKT · 12,635,875 sh · amendment · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive · amendment
- Stake
- 8.9%
- Last report
- 9.99% · filed 26/02/17
- Shares held
- 12,635,875 sh
- Class
- Common Stock, $0.001 par value
- Holder
- Perceptive Advisors
- Event date
- 26/03/31
- Filed
- 26/05/15
8.9% stake · −1.1pp from the last report
- Stake
- 8.9%
- Last report
- 9.99%
- Since last report
- −1.1pp
Inhibikase Therapeutics trades, last 26 weeks
What else happened in Inhibikase Therapeutics around then
Filed or reported within 30 days of the trade day · 03/01~04/30Perceptive Advisors's other 5% stake reports
- Perceptive Advisors
5% stakeNurix Therapeutics
5% stakeNurix Therapeutics
NRIX
5.3% stake
5,536,629 sh
5.3% stake
Filed 09/23
- Perceptive Advisors
5% stakeImmatics
5% stakeImmatics
IMTX
7.6% stake
11,418,016 sh
7.6% stake
Filed 08/27
- Perceptive Advisors
5% stakeLeonaBio
5% stakeLeonaBio
LONA
19.99% stake
1,889,403 sh
19.99% stake
Filed 08/25
- Perceptive Advisors
5% stakeSolid Biosciences
5% stakeSolid Biosciences
SLDB
11.2% stake
12,046,579 sh
11.2% stake
Filed 08/14
- Perceptive Advisors
5% stakeSpyre Therapeutics
5% stakeSpyre Therapeutics
SYRE
4.9% stake
4,319,496 sh
4.9% stake
Filed 08/14
